144 related articles for article (PubMed ID: 9657738)
1. A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.
Blay JY; Le Cesne A; Mermet C; Maugard C; Ravaud A; Chevreau C; Sebban C; Guastalla J; Biron P; Ray-Coquard I
Blood; 1998 Jul; 92(2):405-10. PubMed ID: 9657738
[TBL] [Abstract][Full Text] [Related]
2. Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.
Ray-Coquard I; Le Cesne A; Rubio MT; Mermet J; Maugard C; Ravaud A; Chevreau C; Sebban C; Bachelot T; Biron P; Blay JY
J Clin Oncol; 1999 Sep; 17(9):2840-6. PubMed ID: 10561360
[TBL] [Abstract][Full Text] [Related]
3. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay JY; Chauvin F; Le Cesne A; Anglaret B; Bouhour D; Lasset C; Freyer G; Philip T; Biron P
J Clin Oncol; 1996 Feb; 14(2):636-43. PubMed ID: 8636781
[TBL] [Abstract][Full Text] [Related]
4. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY;
Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
Isaacs C; Robert NJ; Bailey FA; Schuster MW; Overmoyer B; Graham M; Cai B; Beach KJ; Loewy JW; Kaye JA
J Clin Oncol; 1997 Nov; 15(11):3368-77. PubMed ID: 9363868
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Merkel Cell Carcinoma Complicated with Severe Thrombocytopenia Treated with Carboplatin/Etoposide Regimen after Surgery].
Saito Y; Kiba T; Takahashi T; Hirakawa H; Saito M; Otomo C; Sato M; Watanabe Y; Sakaguchi M; Kadota R; Noguchi N; Suzuki T; Awataguchi T; Shoji F; Ota N
Gan To Kagaku Ryoho; 2017 Aug; 44(8):685-687. PubMed ID: 28860441
[TBL] [Abstract][Full Text] [Related]
10. Current issues with platelet transfusion in patients with cancer.
McCullough J
Semin Hematol; 2000 Apr; 37(2 Suppl 4):3-10. PubMed ID: 10831283
[TBL] [Abstract][Full Text] [Related]
11. Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer.
Matsumoto N; Mizuno T; Ando Y; Kato K; Nakanishi M; Nakai T; Lee JK; Kameya Y; Nakamura W; Takahara K; Shiroki R; Yamada S
Clin Drug Investig; 2024 May; 44(5):357-366. PubMed ID: 38684605
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
13. Platelet support and the use of cytokines.
Bishop JF
Stem Cells; 1994 Jul; 12(4):370-7. PubMed ID: 7524892
[TBL] [Abstract][Full Text] [Related]
14. Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants.
Sparger KA; Assmann SF; Granger S; Winston A; Christensen RD; Widness JA; Josephson C; Stowell SR; Saxonhouse M; Sola-Visner M
JAMA Pediatr; 2016 Jul; 170(7):687-94. PubMed ID: 27213618
[TBL] [Abstract][Full Text] [Related]
15. Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.
Ray-Coquard I; Borg C; Bachelot T; Sebban C; Philip I; Clapisson G; Le Cesne A; Biron P; Chauvin F; Blay JY;
Br J Cancer; 2003 Jan; 88(2):181-6. PubMed ID: 12610500
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia.
Takahashi M; Takahashi K; Kaneda H; Kawaguchi T; Nagayama K
Anticancer Res; 2021 Nov; 41(11):5729-5737. PubMed ID: 34732446
[TBL] [Abstract][Full Text] [Related]
17. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
18. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.
Abrams-Ogg AC
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205
[TBL] [Abstract][Full Text] [Related]
19. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
